Cart
sales@molnova.com
WZ811
CAS No. 55778-02-4
WZ811( WZ811 | WZ-811 | WZ 811 )
Catalog No. M15027 CAS No. 55778-02-4
WZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 167 | In Stock |
|
| 100MG | 233 | In Stock |
|
| 200MG | 302 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWZ811
-
NoteResearch use only, not for human use.
-
Brief DescriptionWZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
-
DescriptionWZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsWZ811 | WZ-811 | WZ 811
-
PathwayAutophagy
-
TargetCXCR
-
RecptorCXCR4
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number55778-02-4
-
Formula Weight290.36
-
Molecular FormulaC18H18N4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL (103.32 mM)
-
SMILESC1(CNC2=NC=CC=C2)=CC=C(CNC3=NC=CC=C3)C=C1
-
Chemical NameN,N'-(1,4-phenylenebis(methylene))bis(pyridin-2-amine)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhan W, et al. J Med Chem, 2007, 50(23), 5655-5664.
molnova catalog
related products
-
Mogamulizumab
Mogamulizumab (KW-0761) is a monoclonal antibody targeting T cell CC chemokine receptor 4.
-
TC14012
TC14012, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 has anti-HIV activity and anti-cancer activity.
-
AZD8797
AZD8797 (KAND567) is an orally available, selective and potent human CX3CR1-converting antagonist with inhibitory effects on CX3CR1 and CXCR2.
